Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-21

Clinical Trial Update: Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia [NA]

View source ↗

Summary

A completed clinical trial evaluated whether diet, exercise, niacin, and fenofibrate could reduce cardiovascular risk factors in people with HIV lipodystrophy o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)
  • Niacin (nicotinic acid)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Cardiovascular Diseases, Heart Diseases | NA | Status: COMPLETED | Results posted: 2016-03-21